Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Tenor Capital Management
Quarter-by-quarter ownership of Neurocrine Biosciences Inc Note 2.250 5/1 shares owned by Tenor Capital Management
from 13F filings
Historical chart of Tenor Capital Management investment in Neurocrine Biosciences Inc Note 2.250 5/1
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences Inc Note 2.250 5/1 held by Tenor Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences Inc Note 2.250 5/1 by Tenor Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $47B | 27M | 1744.10 |
| 2023-09-30 | $40B | 27M | 1498.71 |
| 2023-06-30 | $27M | 21M | 1.28 |
| 2023-03-31 | $27M | 19M | 1.36 |
| 2022-12-31 | $4.8M | 3.0M | 1.59 |
| 2022-09-30 | $4.3M | 3.0M | 1.43 |
| 2022-03-31 | $60M | 45M | 1.33 |
| 2021-12-31 | $57M | 45M | 1.26 |
| 2021-09-30 | $61M | 45M | 1.35 |
| 2021-06-30 | $61M | 45M | 1.33 |
| 2021-03-31 | $62M | 45M | 1.36 |
| 2020-09-30 | $4.9M | 3.5M | 1.39 |
Top funds holding Neurocrine Biosciences Inc Note 2.250 5/1
View all funds holding Neurocrine Biosciences Inc Note 2.250 5/1